Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 6/20 | 0.53 |
| ▸ | MAP3K7 | O43318 | 4/20 | 0.53 |
| ▸ | MAP4K2 | Q12851 | 4/20 | 0.53 |
| ▸ | RAF1 | P04049 | 5/20 | 0.49 |
| ▸ | BRAF | P15056 | 4/20 | 0.49 |
| ▸ | ABL1 | P00519 | 5/20 | 0.48 |
| ▸ | SRC | P12931 | 4/20 | 0.48 |
| ▸ | MAP3K20 | Q9NYL2 | 3/20 | 0.48 |
| ▸ | FES | P07332 | 3/20 | 0.48 |
| ▸ | FER | P16591 | 3/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.48 |
| ▸ | LYN | P07948 | 2/20 | 0.48 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.48 |
| ▸ | EPHB2 | P29323 | 2/20 | 0.48 |
| ▸ | FLT3 | P36888 | 2/20 | 0.48 |
| ▸ | CSK | P41240 | 2/20 | 0.48 |
| ▸ | ABL2 | P42684 | 2/20 | 0.48 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.48 |
| ▸ | MKNK2 | Q9HBH9 | 6/20 | 0.48 |
| ▸ | MKNK1 | Q9BUB5 | 5/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23353517 | 0.96 | MAPK14 (0.54) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL21470935 | 0.95 | MAPK14 (0.52) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL23353688 | 0.95 | MAPK14 (0.47) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL21470794 | 0.94 | MAPK14 (0.46) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL21470934 | 0.93 | MAPK14 (0.53) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL23353605 | 0.93 | MAPK14 (0.54) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL23353742 | 0.91 | MAPK14 (0.53) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL23353666 | 0.90 | MAPK14 (0.54) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL23353513 | 0.89 | MAPK14 (0.55) | MAPK14MAP3K7MAP4K2RAF1BRAF | |
| SCHEMBL21470689 | 0.89 | MAPK14 (0.67) | MAPK14MAP3K7MAP4K2RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139484-A1 | DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | GOSSAMER BIO SERVICES INC (US) | 2021-05-13 | — | — | US | disclosed |
| WO-2019200120-A1 | DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | LYCERA CORPORATION (US) | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139484-A1 | DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | ULK1, PHKG2, PHKG1 | MAPK14 1056/4885MAP3K7 106/4885MAP4K2 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.